Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 2Phase 3 2Phase 1 2Phase NA 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 2

Conditions

Keratosis, Actinic 2Hemangioma 2

Interventions

Cyclophosphamide 517Bevacizumab 488Carboplatin 424pembrolizumab 388Paclitaxel 385Gemcitabine 372Cisplatin 366Docetaxel 323Rituximab 316Radiotherapy 296Nivolumab 247Doxorubicin 243Dexamethasone 240Fluorouracil 225Capecitabine 214Oxaliplatin 211Erlotinib Hydrochloride 206fludarabine phosphate 201Etoposide 188Cetuximab 186Lenalidomide 177Pemetrexed 176Bortezomib 174Trastuzumab 173Filgrastim 171fludarabine 166Prednisone 166Leucovorin 166Cytarabine 166Irinotecan 161

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Has results × Solutions × Clear all
NCT01074437 2018-10-04

Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)

Seattle Children's Hospital

Phase 2 Terminated
9 enrolled 5 charts

Hemangioma

NCT02239679 2018-08-24

Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy

DUSA Pharmaceuticals, Inc.

Phase 2 Completed
166 enrolled 79 charts
Dermatologic

Keratosis, Actinic

NCT02632110 2018-01-18

Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face

DUSA Pharmaceuticals, Inc.

Phase 2 Completed
137 enrolled 58 charts
Dermatologic

Keratosis, Actinic

NCT00555464 2013-06-11

Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas

Medical College of Wisconsin

Phase 2 Terminated
8 enrolled 7 charts

Hemangioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡